Sign In
Buy APLT
$0.0959
+0 (+0%)
At Close: Apr 28, 2026
COVID-19 actions - healthcare
11:44am, Thursday, 02'nd Apr 2020
FDA signs off on Emergency Use Authorization for Humanigen's (OTCQB:HGEN) lenzilumab for compassionate use for preventing and treating cytokine storm in severely ill COVID-19 patients.Investigator-ini
Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients
11:00am, Thursday, 02'nd Apr 2020
Applied Therapeutics Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical nee
Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results
11:00am, Friday, 13'th Mar 2020
NEW YORK, March 13, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against.
Applied Therapeutics to Present at the Barclays Global Healthcare Conference
11:00am, Tuesday, 10'th Mar 2020
Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical ne
Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer
12:00pm, Tuesday, 03'rd Mar 2020
Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today announced the appointment of Adam Hansar
Applied Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference
09:05pm, Wednesday, 26'th Feb 2020
Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical ne
The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis
US Dollar Flexes Muscles Against Other Currencies: 5 Winners
12:03pm, Thursday, 20'th Feb 2020
The US dollar drew support from a healthy domestic economy, and Fed's cautiously optimistic stance about holding interest rates despite the coronavirus outbreak.
3 Top Biotech Stocks to Buy in February
01:29pm, Sunday, 09'th Feb 2020
These three clinical-stage biotechs could all double in value before year's end.
5 Growth Stocks That Are as Hot as Tesla
04:17pm, Friday, 07'th Feb 2020
While the record rally in Tesla stock has garnered all the attention over the past six months, these growth stocks have been just as hot.
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
12:43pm, Wednesday, 05'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Daily Insider Ratings Round Up 1/29/20
06:42pm, Friday, 31'st Jan 2020
Tables of the top insider purchases and sales filed with the SEC on 1/29/20, based on dollar value. Dollar values often do not equate with significance when it
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
02:09pm, Friday, 31'st Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (
Applied Therapeutics, Inc. (APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of h
The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study
12:43pm, Friday, 24'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 23) Baudax Bio Inc (NASDAQ: BXRX ) Mesoblast limited (
